AdaptHealth Corp. 8K

AdaptHealth Corp. agreed to sell its Diabetes Health business to Cardinal Health for $235 million in cash to refocus on core operations and strengthen its balance sheet, with closing subject to regulatory and customary conditions.

AdaptHealth Corp. announced that it has entered into a definitive agreement, signed on July 19, 2026, to divest its Diabetes Health business to Cardinal Health for $235 million in cash, subject to customary purchase price adjustments and regulatory review under the Hart-Scott-Rodino Act and other standard closing conditions; the transaction is intended to sharpen AdaptHealth’s strategic focus on its core sleep, respiratory, and home medical equipment businesses, improve its expected revenue growth profile and adjusted EBITDA margins, enhance capital flexibility for reinvestment and debt reduction to accelerate deleveraging and strengthen its balance sheet, and will result in the Diabetes Health segment being reported as discontinued operations, with further financial and guidance details to be provided on AdaptHealth’s second quarter 2026 earnings call scheduled for August 4, 2026.

Filing Facts

CIK

1725255

Ticker

-

Form

8K

Source Type

sec

Accession

0001104659-26-085086

Alert Tier

7